PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats-Reference-Cited by-同舟云学术

PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats

Published:2018-02 Issue: Volume:395 Page:15-22
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Andersen Michael Aagaard,Wegener Karen Malene,Larsen Steen,Badolo Lassina,Smith Garrick Paul,Jeggo Ross,Jensen Poul Henning,Sotty Florence,Christensen Kenneth Vielsted,Thougaard Annemette

Funder

Kirsten Christensen

Danish Innovation Foundation for financial support

Publisher

Elsevier BV

Subject

Toxicology

Reference25 articles.

1. Bovine renal lipofuscinosis: prevalence, genetics and impact on milk production and weight at slaughter in Danish cattle;Agerholm;Acta Vet. Scand.,2009

2. Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs;Baptista;PLoS One,2013

3. LRRK2 kinase inhibitors of different structural classes induce abnormal accumulation of lamellar bodies in type II pneumocytes in non-human primates but are reversible and without pulmonary functional consequences;Baptista;Workflow and Study Design,2015

4. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations;Bundgaard;Xenobiotica,2012

5. Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates α-Synuclein gene-induced neurodegeneration;Daher;J. Biol. Chem.,2015

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date;Expert Opinion on Therapeutic Patents;2024-07-19

2. Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine;Frontiers in Aging Neuroscience;2024-07-04

3. LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression;Translational Neurodegeneration;2024-03-04

4. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage;npj Parkinson's Disease;2024-03-01

5. Knocking out the LRRK2 gene increases sensitivity to wavelength information in rats;Scientific Reports;2024-02-29